Associated Papers
Prime editing-installed suppressor tRNAs for disease-agnostic genome editing.
Pierce SE et al.
Nature, 2025
41261131 (PubMed )
Supplement: 41586_2025_9732_MOESM17_ESM.xlsx › Sequence_Context_Screen
48-Year clinical experience and genetic analysis of pediatric primary hyperparathyroidism from a single center in China.
Chen Y et al.
Journal of Endocrinological Investigation, 2025
Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of CDC73 Gene and Parafibromin-Deficient Tumours.
Gheorghe AM et al.
International Journal of Molecular Sciences, 2024
Genetic Alteration Profiles and Clinicopathological Associations in Atypical Parathyroid Adenoma.
Mao X et al.
International Journal of Genomics, 2021
33778063 (PubMed )
Supplement: 6666257.f1.zip › Supplemental_Table_2__1_.pdf
The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
Hu Y et al.
International Journal of Cancer, 2020
Preliminary exploration of potential molecular therapeutic targets in recurrent and metastatic parathyroid carcinomas.
Cui M et al.
International Journal of Cancer, 2019
Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L et al.
Human Mutation, 2017
Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
Kong J et al.
Clinical Endocrinology, 2014
Select a paper to view details